Analytical Specificity of Bladder EpiCheck Test in Healthy Population and Urology Patients Without Prior History or Evidence of Bladder Cancer

CompletedOBSERVATIONAL
Enrollment

168

Participants

Timeline

Start Date

September 5, 2019

Primary Completion Date

January 8, 2020

Study Completion Date

January 8, 2020

Conditions
Non Muscle Invasive Bladder CancerNon-Muscle Invasive Bladder Urothelial Carcinoma
Interventions
DIAGNOSTIC_TEST

Bladder EpiCheck

Bladder EpiCheckTM (EpiCheck) is a urine test for monitoring of recurrence of NMIBC based on analysis of 15 informative DNA methylation biomarkers.

Trial Locations (1)

78229

Urology San Antonio, San Antonio

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Nucleix Ltd.

INDUSTRY

NCT06020807 - Analytical Specificity of Bladder EpiCheck Test in Healthy Population and Urology Patients Without Prior History or Evidence of Bladder Cancer | Biotech Hunter | Biotech Hunter